POPULATION, ABORTION AND HUMAN RIGHTS IN BRAZIL: the case of the use of misoprostol in the illegality in the country

Brazilian state, by means of Anvisa – National Agency for Sanitary Vigilance AgênciaNacional de Vigilância Sanitária) has issued norms that restrain the dissemination of information on sexual and reproductive health, especially concerning the use of misoprostol. This medicine has been increasingly controlled in the country since the 1980s. In 1998, Anvisa issued Regulation 344 /1998 which limited the access to the drug only to hospital facilities, hence preventing access to misoprostol by people in drugstores. At present it attempts to control the flow of information on the drug at internet sites and social networks, by means of Resolutions No. 911/2006 and No.1050/2006, updated by Resolution 1534 of April, 2011 Besides questioning the Anvisa competence to rule on such matter, the papers will show that violation of the right to information can not follow the existing restraints to access to the drug itself. Medicine abortion may be legally provided by the Brazilian health national system (SUS) in the cases of rape and risk to women’s life1. If women have access to such health technology by diverse means, they must not be prevented from having access to information on how to safely